Cargando…

Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients

BACKGROUND: Lung dose-volume histogram (DVH) in radiotherapy could be calculated from multiple normal lung definitions. The lung dosimetric parameters generated from various approaches are significantly different. However, limited evidence shows which definition should be used to more accurately pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Yinnan, Yang, Haihua, Wang, Wei, Tang, Xingni, Jiang, Caiping, Shen, Yichao, Luo, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332547/ https://www.ncbi.nlm.nih.gov/pubmed/30642354 http://dx.doi.org/10.1186/s13014-018-1204-x

Ejemplares similares

Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
por: Meng, Yinnan, et al.
Publicado: (2020)

Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose Constraints
por: Harris, Wendy B., et al.
Publicado: (2020)

Lung Stereotactic Body Radiation Therapy (SBRT) dose gradient and PTV volume: a retrospective multi-center analysis
por: Hoffman, David, et al.
Publicado: (2019)

Excluding Lung Tissue from the PTV during Internal Mammary Irradiation. A Safe Technique for OAR-Sparing?
por: Borm, Kai J., et al.
Publicado: (2021)

Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer
por: Tatsuno, Saori, et al.
Publicado: (2022)

Radiation pneumonitis and pulmonary function with lung dose–volume constraints in breast cancer irradiation
por: Blom Goldman, U., et al.
Publicado: (2013)

Bilateral diffuse grade 5 radiation pneumonitis after intensity modulated radiation therapy for localized lung cancer
por: Osborn, Virginia W, et al.
Publicado: (2017)

Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis
por: Uchida, Yasuki, et al.
Publicado: (2017)

Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design
por: Moiseenko, Vitali, et al.
Publicado: (2020)

The prognostic value of circulating lymphocyte counts and ABO blood group in lung cancer stereotactic body radiation therapy: a retrospective study
por: Chen, Meng, et al.
Publicado: (2022)

Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient
por: Hosono, Yuki, et al.
Publicado: (2017)

Curcumin Mitigates Radiation-induced Lung Pneumonitis and Fibrosis in Rats
por: Amini, Paiman, et al.
Publicado: (2018)

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
por: Ding, Xiao, et al.
Publicado: (2011)

Lung stereotactic body radiation therapy: personalized PTV margins according to tumor location and number of four-dimensional CT scans
por: Trémolières, Pierre, et al.
Publicado: (2022)

A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation
por: Shi, Hua-shan, et al.
Publicado: (2012)

Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer
por: Jiao, Yuxin, et al.
Publicado: (2020)

Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy
por: Li, Fangjuan, et al.
Publicado: (2021)

Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients
por: Li, Bing, et al.
Publicado: (2022)

An analytical expression for R50% dependent on PTV surface area and volume: a lung SBRT comparison
por: Desai, Dharmin D., et al.
Publicado: (2020)

Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
por: Inoue, Hiroto, et al.
Publicado: (2020)

Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer
por: Torresan, Sara, et al.
Publicado: (2023)

Predictive Factors for Radiation Pneumonitis in Lung Cancer Treated with Helical Tomotherapy
por: Kim, Youngkyong, et al.
Publicado: (2013)

Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer
por: Castillo, Richard, et al.
Publicado: (2014)

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab
por: Shaverdian, Narek, et al.
Publicado: (2020)

Association of DNA repair gene polymorphisms with the risk of radiation pneumonitis in lung cancer patients
por: Du, Lehui, et al.
Publicado: (2017)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
por: Lu, Xiaotong, et al.
Publicado: (2022)

Effects of diabetes on the development of radiation pneumonitis
por: Dong, Guangtong, et al.
Publicado: (2021)

Pretreatment Factors Influencing Radiation Pneumonitis after Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
por: Harris, Alexander A, et al.
Publicado: (2020)

Single-Cell Transcriptome Analysis of Radiation Pneumonitis Mice
por: Yang, Miaomiao, et al.
Publicado: (2022)

On the pitfalls of PTV in lung SBRT using type-B dose engine: an analysis of PTV and worst case scenario concepts for treatment plan optimization
por: Leung, Ronnie Wing King, et al.
Publicado: (2020)

Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis
por: Lee, Yun Hee, et al.
Publicado: (2015)

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy
por: Noda‐Narita, Shoko, et al.
Publicado: (2022)

High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis
por: Szejniuk, Weronika Maria, et al.
Publicado: (2021)

Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues
por: Yu, Hsin-Hsien, et al.
Publicado: (2018)

Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors
por: Yamashita, Hideomi, et al.
Publicado: (2007)

The TGF-β1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients
por: Kim, Ji-Yoon, et al.
Publicado: (2009)

Genetic variants of SP‐D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy
por: Xu, Li, et al.
Publicado: (2019)

Impact of genetic variant of HIPK2 on the risk of severe radiation pneumonitis in lung cancer patients treated with radiation therapy
por: Tang, Yang, et al.
Publicado: (2020)

Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Multiple Pulmonary Oligometastases or Synchronous Primary Lung Cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Decreased risk of radiation pneumonitis with concurrent use of renin-angiotensin system inhibitors in thoracic radiation therapy of lung cancer
por: Zheng, Yawen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tcuupi7d3r5eqhgkm0ps0buemd